Carrillo-Esper Raúl, Mejía-Gómez Leslian, Monares-Zepeda Enrique, Chavarría-Martínez Uriel, Díaz-Carrillo Alejandro, Ayala-León Miguel, Zamora-Gómez Sergio, Sánchez-Díaz Jesús S, Lomelí-Terán Manuel, Briones-Garduño Jesús C, Pérez-Calatayud Ángel A
Academia Mexicana de Cirugía, Ciudad de México, México.
Servicio de Anestesiología, Unidad Médica de Alta Especialidad, Hospital de Traumatología y Ortopedia, Lomas Verdes, Estado de México, México.
Cir Cir. 2020;88(6):805-817. doi: 10.24875/CIRU.20000301.
The severe acute respiratory syndrome (SARS-Cov-2) is a clinical entity generated by this new virus a Coronavirus (COVID-19). Disease called COVID-19 (CoronaVIrus Disease 2019) by the World Health Organization. Its presentation is acute respiratory failure characterized by hyperinflation of the lung that leads to an increase in capillaries and epithelial permeability, with loss of ventilation of lung tissue and increases lung stiffness. These disturbances lead to imbalances between ventilation and perfusion ratio, which ultimately result in hypoxemia and impaired carbon dioxide clearance. For this review, a search of PubMed and Trip Database was performed. Due to the scarcity of publications, a specific search algorithm was not used. The objective is to review, the evidence and the recommendations of national and international experts, of the hemodynamic and ventilatory management of these patients.
严重急性呼吸综合征(SARS-CoV-2)是由这种新型冠状病毒(COVID-19)引发的一种临床病症。世界卫生组织将该疾病称为COVID-19(2019冠状病毒病)。其表现为急性呼吸衰竭,特征是肺部过度充气,导致毛细血管和上皮通透性增加,肺组织通气丧失且肺硬度增加。这些紊乱导致通气与灌注比例失衡,最终造成低氧血症和二氧化碳清除受损。为进行本综述,我们检索了PubMed和Trip数据库。由于出版物数量稀少,未使用特定的检索算法。目的是综述国内外专家关于这些患者血流动力学和通气管理的证据及建议。